Introduction
As a Mediterranean country, the frequencies of thalassemias and hemoglobinopathies are fairly high in Turkey. The majority of hemoglobin variants are clinically silent. They are usually recognised by chance during investigation of another health problem, mostly during the HbA 1c measurement.
Hb Beckman was firstly described first by Rahbar et The samples were collected from the family members of the patient (mother, daughter and niece) for total blood count and the presence of the hemoglobin variant analysis.
We obtained an informed consent to participation in the study from the patient and his family. The study was approved by the Ethic Committee of Dr. Lütfi Kırdar Kartal Training and Research Hospital. The hematological parameters were measured using a routine blood count analyser (Sysmex XT 2000i, Roche Diagnostic). Except for some mild decreases, most of the hematological markers were found to be between the reference range ranges. DNA isolation was carried out using a commercially available DNA extraction kit (RTA Lab, Ltd., Sti, Tür-kiye). Beta globin gene regions were sequenced with an ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA., USA). ABIPRISM 310 genetic analyzer (Applied Biosystems, Foster City, California, USA) was used to analyze sequence reaction.
Results
The samples of the patient and family members, evaluated for the presence of a variant by two CE-HPLC methods gave the results that are shown in Table 1 . The chromatogram of the patient, showed a peak with an area of % 49.1 eluting at LHbA 1c /CHb-1 fraction with D-10 (Bio-Rad) (figure not shown) and a peak eluting after HbA 1c with an area of % 46.7 with Ultra 2 -Variant (Trinity-Biotech) (Fig. 1) . The chromatograms of three members of the family showed the same peaks. Beta globin gene sequencing analysis revealed a heterozygote codon 135 GCT-GAT (Ala --> Asp) mutation which was identical to the Hemoglobin Beckman.
Discussion
Our patient is the first individual with Hb Beckman detected in Turkey. To our knowledge, after Rahbar's and Kim's, this is the third case reported worldwide. [3, 4] . HbA 1c analysing methods are mainly based on either molecular charge (ion exchange chromatography, electrophoresis) or structure (immunoassays, boronate affinity chromatography, mass spectrophotometry). All of these methods, except for mass spectrophotometry which is an expensive and complicated one, are widely used in routine laboratories for HbA 1c measurement. The former methods are affected by the posttranslational modifications or mutations that alter the charge of the molecule resulting in co-elution or co-migration of the variant with Hb A or HbA 1c . On the other hand, any mutation at the N-terminal of β chain that affects the antibody recognition may cause an incorrect HbA 1c result in immunoassay methods. The boronate affinity methods measure only glycated Hb regardless of the glycation site.
Although there are few exceptions like Hb Raleigh [5] or Hb Himeji [6] , the boronate affinity methods are not affected by most of the variants. Although HbA 1c measurement is the best indicator of the long-term glycemic control, the laboratories must be aware of the presence of Hb variants that could interfere with their methodology and should have an alternative way to obtain a true HbA 1c value. The measurement of fructosamine, daily multiple testing of glucose or continuous glucose monitoring for hospitalized patients are suggested for this purpose. These tests can also be useful in patients with altered erythrocyte life span or altered glycation. However, measurement of HbA 1c with a boronate affinity method can be a reliable diagnostic tool in most of the cases like ours. This new case of Hb Beckman is thought to be a modest contribution to the subject of abnormal hemoglobins that interfere with HbA 1c measurement. We presume that in countries like Turkey where Hb variants are quite frequent, the awareness of the interference of these abnormal hemoglobins by the laboratorians and the clinicians is crucial.
